Bioluminosity is founded in 2020, we aim to develop novel drug and take on commission to advance various biotechnological products. Currently, we are focusing on developing protein drugs which apply to treat age-related macular degeneration, diabetic retinopathy, and other ocular diseases. We hope our effort contributing to the progress of medicine and enhancing patient care in the future.